HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Clinical trials for HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.

Never miss a new study

Get alerted when new HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

Sign up with your email to follow new studies for HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3

New drug combo tested for Life-Threatening immune overreaction in cancer patients

Disease control Recruiting now

This study is testing a combination of existing drugs to treat a dangerous immune system overreaction called HLH in people with B-cell lymphoma. The goal is to control this severe complication and improve survival. About 40 patients will receive the drug combination for 4 weeks, …

Matched conditions: HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Phase: PHASE4 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Get alerted when new HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

New drug combo tested for Life-Threatening immune overreaction in cancer patients